Over a dozen states are suing the Trump administration to block a controversial rollback of childhood vaccine recommendations, citing public health risks.
FDA grants Breakthrough Therapy status to luvesilocin (RE104), a single-dose psychedelic treatment for postpartum depression offering remission in days.
